Oscar Health has a lot of opportunities with the growth of Health Reimbursement Arrangements. See why OSCR stock is a buy ...

The summary covers recent significant developments in health news including Warren Buffett's Berkshire Hathaway's investment in UnitedHealth Group and the struggles of the UK's bioethanol industry due ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...

Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...

Novo Nordisk (NVO) announced that the US Food and Drug Administration has approved an additional indication for Wegovy based ...

Bullish flow in Novo Nordisk (NVO), with shares up $1.52, or 2.99%, near $52.48. Options volume roughly in line with average with 102k contracts ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

U.S. equities were mixed at midday following the release of the July retail sales report, which came in as expected.

HIMS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

A spokesperson for Hims did not immediately respond to a request for comment. The company previously said it was cooperating ...

US stocks opened mixed Friday as strong retail sales data offset hotter wholesale inflation, with UnitedHealth surging on ...